Location: New York, NY
CIK: 0001493215 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $4.74B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS INC | 17,687,772 | $362M | 7.6% | $17.75 | +2.4% | COM | 77313F106 |
| IMCR | IMMUNOCORE HLDGS PLC | 6,096,387 | $316M | 6.7% | $43.23 | — | ADS | 45258D105 |
| AXSM | AXSOME THERAPEUTICS INC | 4,489,596 | $314M | 6.6% | $55.43 | +34.9% | COM | 05464T104 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,683,362 | $298M | 6.3% | $95.85 | +99.4% | COM | 02043Q107 |
| — | MIRATI THERAPEUTICS INC | 6,768,514 | $295M | 6.2% | $59.30 | — | COM | 60468T105 |
| ARGX | ARGENX SE | 507,195 | $249M | 5.3% | $332.91 | — | SPONSORED ADR | 04016X101 |
| ACAD | ACADIA PHARMACEUTICALS INC | 11,576,537 | $241M | 5.1% | $20.61 | +31.8% | COM | 004225108 |
| BRKR | BRUKER CORP | 3,381,703 | $211M | 4.4% | $72.95 | -8.6% | COM | 116794108 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 5,405,089 | $193M | 4.1% | $53.89 | -26.5% | COM | 90400D108 |
| PEN | PENUMBRA INC | 673,371 | $163M | 3.4% | $259.17 | +7.1% | COM | 70975L107 |
| PTCT | PTC THERAPEUTICS INC | 7,235,196 | $162M | 3.4% | $38.43 | -3.2% | COM | 69366J200 |
| TMO | THERMO FISHER SCIENTIFIC INC | 290,334 | $147M | 3.1% | $545.57 | -3.1% | COM | 883556102 |
| MASI | MASIMO CORP | 1,501,493 | $132M | 2.8% | $166.52 | -30.1% | COM | 574795100 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 2,494,138 | $122M | 2.6% | $27.31 | +118.9% | COM | G31249108 |
| NTRA | NATERA INC | 2,651,783 | $117M | 2.5% | $42.76 | +19.3% | COM | 632307104 |
| VCEL | VERICEL CORP | 3,291,873 | $110M | 2.3% | $13.91 | +149.3% | COM | 92346J108 |
| — | SAGE THERAPEUTICS INC | 5,149,482 | $106M | 2.2% | $20.58 | — | COM | 78667J108 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 3,463,201 | $95.31M | 2.0% | $11.47 | +173.3% | COM NEW | 15117B202 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 5,415,514 | $90.33M | 1.9% | $21.97 | -11.7% | COM | 74366E102 |
| CYTK | CYTOKINETICS INC | 2,574,198 | $75.84M | 1.6% | $26.72 | +24.6% | COM NEW | 23282W605 |
| — | AVADEL PHARMACEUTICALS PLC | 7,136,415 | $73.51M | 1.6% | $9.17 | — | SPONSORED ADR | 05337M104 |
| TXG | 10X GENOMICS INC | 1,519,956 | $62.7M | 1.3% | $61.32 | -15.2% | CL A COM | 88025U109 |
| TSHA | TAYSHA GENE THERAPIES INC | 16,893,185 | $53.38M | 1.1% | $1.87 | 0.0% | COM SHS | 877619106 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,880,701 | $51.19M | 1.1% | $25.06 | -29.4% | COM | 87650L103 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 5,620,640 | $49.01M | 1.0% | $11.90 | -43.5% | COM | 68572M106 |
| INSM | INSMED INC | 1,865,108 | $47.09M | 1.0% | $20.78 | +10.1% | COM PAR $.01 | 457669307 |
| — | MERUS N V | 1,996,764 | $47.08M | 1.0% | $25.03 | — | COM | N5749R100 |
| APGE | APOGEE THERAPEUTICS INC | 2,142,591 | $45.64M | 1.0% | $22.03 | 0.0% | COM | 03770N101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 309,485 | $45.2M | 1.0% | $247.37 | -23.9% | COM | 558868105 |
| RNAM | AVIDITY BIOSCIENCES INC | 6,689,789 | $42.68M | 0.9% | $25.00 | -65.5% | COM | 05370A108 |
| GHRS | GH RESEARCH PLC | 3,327,129 | $33.44M | 0.7% | $17.34 | -33.4% | ORDINARY SHARES | G3855L106 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 500,000 | $28.5M | 0.6% | $6.29 | +778.3% | CLASS A ORD | 61559X104 |
| FULC | FULCRUM THERAPEUTICS INC | 5,818,804 | $25.84M | 0.5% | $10.55 | -58.6% | COM | 359616109 |
| ILMN | ILLUMINA INC | 188,125 | $25.83M | 0.5% | $341.04 | -51.8% | COM | 452327109 |
| ALKS | ALKERMES PLC | 889,073 | $24.9M | 0.5% | $29.32 | 0.0% | SHS | G01767105 |
| — | AXONICS INC | 442,487 | $24.83M | 0.5% | $21.35 | — | COM | 05465P101 |
| — | SHOCKWAVE MED INC | 124,000 | $24.69M | 0.5% | $199.10 | — | COM | 82489T104 |
| — | SCPHARMACEUTICALS INC | 3,297,843 | $23.48M | 0.5% | $9.07 | — | COM | 810648105 |
| ROIV | ROIVANT SCIENCES LTD | 1,552,717 | $18.14M | 0.4% | $8.28 | +36.6% | SHS | G76279101 |
| STOK | STOKE THERAPEUTICS INC | 4,390,558 | $17.3M | 0.4% | $24.53 | -73.2% | COM | 86150R107 |
| — | ALLURION TECHNOLOGIES INC | 3,457,707 | $14.87M | 0.3% | $4.30 | — | COM SHS | 02008G102 |
| GH | GUARDANT HEALTH INC | 500,887 | $14.85M | 0.3% | $85.83 | -59.0% | COM | 40131M109 |
| PMVP | PMV PHARMACEUTICALS INC | 2,375,785 | $14.59M | 0.3% | $23.48 | -70.7% | COM | 69353Y103 |
| URGN | UROGEN PHARMA LTD | 857,464 | $12.01M | 0.3% | $15.85 | +1.3% | COM | M96088105 |
| — | CUTERA INC | 1,846,596 | $11.12M | 0.2% | $46.88 | — | COM | 232109108 |
| MIST | MILESTONE PHARMACEUTICALS IN | 3,256,102 | $10.09M | 0.2% | $20.06 | -84.5% | COM | 59935V107 |
| — | ACELYRIN INC | 978,310 | $9.949M | 0.2% | $20.90 | — | COM | 00445A100 |
| IMTX | IMMATICS N.V | 845,000 | $9.785M | 0.2% | $10.42 | +14.5% | SHS | N44445109 |
| — | OUTSET MED INC | 808,658 | $8.798M | 0.2% | $51.37 | — | COM | 690145107 |
| MLYS | MINERALYS THERAPEUTICS INC | 922,100 | $8.769M | 0.2% | $16.83 | -22.5% | COM | 603170101 |
| SYK | STRYKER CORPORATION | 28,000 | $7.652M | 0.2% | $280.01 | 0.0% | COM | 863667101 |
| RLMD | RELMADA THERAPEUTICS INC | 2,131,835 | $6.396M | 0.1% | $29.01 | -89.8% | COM | 75955J402 |
| IMUX | IMMUNIC INC | 4,335,255 | $6.373M | 0.1% | $8.90 | -78.4% | COM | 4525EP101 |
| DSGN | DESIGN THERAPEUTICS INC | 2,512,986 | $5.931M | 0.1% | $5.57 | -16.3% | COM | 25056L103 |
| — | ADICET BIO INC | 4,241,472 | $5.811M | 0.1% | $16.61 | — | COM | 007002108 |
| APYX | APYX MEDICAL CORPORATION | 1,777,194 | $5.687M | 0.1% | $7.55 | -38.3% | COM | 03837C106 |
| DMTKQ | DERMTECH INC | 2,718,356 | $3.914M | 0.1% | $9.75 | — | COM | 24984K105 |
| XGN | EXAGEN INC | 1,492,432 | $3.612M | 0.1% | $11.83 | -78.6% | COM | 30068X103 |
| SGMT | SAGIMET BIOSCIENCES INC | 400,277 | $3.522M | 0.1% | $13.31 | 0.0% | COM SER A | 786700104 |
| VKTX | VIKING THERAPEUTICS INC | 259,400 | $2.872M | 0.1% | $10.33 | +38.5% | COM | 92686J106 |
| — | OLINK HLDG AB | 163,652 | $2.414M | 0.1% | $27.52 | — | SPONSORED ADS | 680710100 |
| — | AKOYA BIOSCIENCES INC | 338,422 | $1.574M | 0.0% | $13.15 | — | COM | 00974H104 |
| — | ARYA SCIENCES ACQU CORP IV | 127,970 | $1.385M | 0.0% | $10.47 | — | CL A | G31659108 |
| — | RAYZEBIO INC | 46,300 | $1.028M | 0.0% | $22.20 | — | COM | 75525N107 |
| — | SIENTRA INC | 304,036 | $845K | 0.0% | $2.78 | — | COM | 82621J204 |
| — | MIROMATRIX MED INC | 445,222 | $583K | 0.0% | $7.95 | — | COM | 60471P108 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 350,000 | $59,500 | 0.0% | $0.11 | — | *W EXP 09/02/202 | 77313F114 |